CheckMan Stock Market Overview

Microsoft Corporation is the worst-performing Magnificent-7 stock YTD, but recent price action signals investor sentiment is turning positive. AI disruption fears have pressured software margins, yet MSFT's business diversity, strong fundamentals, and fortress balance sheet provide resilience. MSFT's revenue grew 15% and EPS 18% last quarter, with Azure up 40%, while ongoing AI and data center investments temporarily compress free cash flow.

Two films that were born out of Alphabet's GOOG-1.31% GOOGL-1.28% YouTube and online culture turned into box-office smashes over the weekend, shattering records and perhaps setting a new model for how Hollywood movies are conceived and made in the future.

Meituan (MPNGY) Q1 2026 Earnings Call Transcript

Iovance Biotherapeutics (NASDAQ:IOVA) said it has obtained clearance of an Investigational New Drug application for IOV-5001, extending its next-generation cell therapy platform into solid tumors the company said account for more than 100,000 US deaths a year. The clearance allows Iovance to begin clinical work on IOV-5001 and marks the platform's move beyond its current focus and into the solid tumor setting.

STRL's Q1 2026 adjusted EPS jumps 120% as revenue surges, backlog hits records, and the company raises its full-year outlook.

New initiatives connect outcomes data, patient voice, and the future of value-based care in orthotics and prosthetics New initiatives connect outcomes data, patient voice, and the future of value-based care in orthotics and prosthetics

Strategy's stock slid Monday after the company disclosed a rare bitcoin sale, rattling investors who have long treated the company as a one-way bet on the cryptocurrency.

Dallas, Texas--(Newsfile Corp. - June 1, 2026) - Initiates Coverage on Postal Realty Trust Inc. (NYSE: PSTL): Stonegate Capital Partners Initiates Coverage on Postal Realty Trust Inc. (NYSE: PSTL). PSTL's 1Q26 update improved the setup by increasing forward revenue visibility and accelerating acquisition capacity at the same time.

GR86 Receives Focused Enhancements for 2027, Including Updated Throttle Calibration, Improved Shift Feel, New Interior Treatments and Expanded Convenience Features New Thunder Exterior Color Highlights GR86's Sculpted Body Lines New Cockpit Red Interior Option Added to Premium Grades 2.4-Liter, 4-Cylinder Boxer Engine Generates 228 Horsepower and 184 lb.-ft. of Torque Available Performance Package Includes Brembo® Brakes and SACHS® Dampers Complimentary 1-year Membership to the National Auto Sport Association Expected to Arrive at Dealerships Summer 2026 PLEASANTON, Calif.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Rallybio Corporation (NASDAQ: RLYB) and Avenzo Therapeutics, Inc. Upon closing of the proposed transaction, Rallybio shareholders are expected to own approximately 2.8% of the combined company.Halper Sadeh encourages Rallybio shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.c.